These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 15105774

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Miglustat-induced intestinal carbohydrate malabsorption is due to the inhibition of α-glucosidases, but not β-galactosidases.
    Amiri M, Naim HY.
    J Inherit Metab Dis; 2012 Nov; 35(6):949-54. PubMed ID: 22976762
    [Abstract] [Full Text] [Related]

  • 23. Replacement therapy with imiglucerase for type 1 Gaucher's disease.
    Zimran A, Elstein D, Levy-Lahad E, Zevin S, Hadas-Halpern I, Bar-Ziv Y, Foldes J, Schwartz AJ, Abrahamov A.
    Lancet; 1995 Jun 10; 345(8963):1479-80. PubMed ID: 7769903
    [Abstract] [Full Text] [Related]

  • 24. Dietary fructose intolerance: diet modification can impact self-rated health and symptom control.
    Johlin FC, Panther M, Kraft N.
    Nutr Clin Care; 2004 Jun 10; 7(3):92-7. PubMed ID: 15624540
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Patients with Gaucher type 1: Switching from imiglucerase to miglustat therapy.
    Canda E, Kose M, Kagnici M, Ucar SK, Sozmen EY, Coker M.
    Blood Cells Mol Dis; 2018 Feb 10; 68():180-184. PubMed ID: 28111116
    [No Abstract] [Full Text] [Related]

  • 27. [Gaucher's disease. Substitutive enzymatic treatment in one case and a review of the literature].
    Rachid M, Harif M, Quessar A, Jabri L, Benchekroun S.
    Tunis Med; 2005 Jan 10; 83(1):43-7. PubMed ID: 15881721
    [Abstract] [Full Text] [Related]

  • 28. Cerezyme--recombinant protein treatment for Gaucher's disease.
    Hoppe H.
    J Biotechnol; 2000 Jan 21; 76(2-3):259-61. PubMed ID: 10656341
    [No Abstract] [Full Text] [Related]

  • 29. Enzyme replacement and gene therapy for Gaucher's disease.
    Brady RO, Barton NW.
    Lipids; 1996 Mar 21; 31 Suppl():S137-9. PubMed ID: 8729108
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Echocardiographic assessment of pulmonary hypertension in Gaucher's disease.
    Elstein D, Klutstein MW, Lahad A, Abrahamov A, Hadas-Halpern I, Zimran A.
    Lancet; 1998 May 23; 351(9115):1544-6. PubMed ID: 10326537
    [Abstract] [Full Text] [Related]

  • 32. Enzyme therapy for Gaucher disease: the first 5 years.
    Grabowski GA, Leslie N, Wenstrup R.
    Blood Rev; 1998 Jun 23; 12(2):115-33. PubMed ID: 9661800
    [Abstract] [Full Text] [Related]

  • 33. The health-related quality of life of adults with Gaucher's disease receiving enzyme replacement therapy: results from a retrospective study.
    Damiano AM, Pastores GM, Ware JE.
    Qual Life Res; 1998 Jul 23; 7(5):373-86. PubMed ID: 9691718
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Course of a case of Gaucher's disease type 1 treated over a year with glucocerebrosidase (Cérédase)].
    Belmatoug N, Azorin M, Huten D, de Villemeur TB, Carbon C.
    Rev Med Interne; 1993 Jul 23; 14(10):996. PubMed ID: 8009089
    [Abstract] [Full Text] [Related]

  • 37. [Enzyme therapy of Gaucher's disease].
    Beck M.
    Dtsch Med Wochenschr; 1993 Jun 25; 118(25):964-5. PubMed ID: 8519225
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Pulmonary involvement of Gaucher's disease in children: a common presentation in Saudi Arabia.
    Banjar H.
    Ann Trop Paediatr; 1998 Mar 25; 18(1):55-9. PubMed ID: 9692003
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.